Hussman Strategic Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,500	Closed	-$447K	–	337
2020 Q4	$447K	Sell	25,500 -25,500	-50%	-$447K	0.12%	239
2020 Q3	$756K	Buy	+51,000	New	+$756K	0.2%	177